Nifty
Sensex
:
:
10283.60
33342.80
68.85 (0.67%)
235.98 (0.71%)

Chemicals

Rating :
54/99   (View)

BSE: 530019 | NSE: JUBILANT

677.85
58.80 (9.50%)
17-Nov-2017 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 624.00
  • 682.65
  • 619.10
  • 619.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 2335860
  • 15833.63
  • 878.00
  • 555.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,765.81
  • 19.74
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 14,351.47
  • 0.44%
  • 2.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.02%
  • 3.12%
  • 13.8%
  • FII
  • DII
  • Others
  • 0.39%
  • 4.77%
  • 23.90%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 17
Sep 16
Var%
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Net Sales
1,642.04
1,385.50
18.52%
1,596.05
1,419.53
12.44%
1,641.42
1,501.27
9.34%
1,458.22
1,379.45
5.71%
Expenses
1,335.98
1,045.17
27.82%
1,258.44
1,051.37
19.70%
1,336.44
1,183.31
12.94%
1,126.40
1,074.44
4.84%
EBITDA
306.06
340.33
-10.07%
337.61
368.16
-8.30%
304.98
317.96
-4.08%
331.82
305.01
8.79%
EBIDTM
18.64%
23.98%
21.15%
25.94%
18.58%
21.18%
22.25%
22.11%
Other Income
7.09
4.92
44.11%
6.81
4.29
58.74%
10.53
2.52
317.86%
5.12
2.85
79.65%
Interest
66.01
79.96
-17.45%
68.73
82.77
-16.96%
80.19
89.93
-10.83%
98.19
90.01
9.09%
Depreciation
79.01
72.01
9.72%
72.48
71.52
1.34%
75.22
126.02
-40.31%
72.65
74.65
-2.68%
PBT
168.13
193.43
-13.08%
203.21
218.26
-6.90%
160.10
120.99
32.32%
166.48
139.96
18.95%
Tax
42.66
49.72
-14.20%
59.50
54.24
9.70%
11.07
50.31
-78.00%
47.99
23.03
108.38%
PAT
125.47
143.71
-12.69%
143.71
164.02
-12.38%
149.03
70.68
110.85%
118.49
116.93
1.33%
PATM
7.64%
10.13%
9.00%
11.55%
9.08%
4.71%
7.94%
8.48%
EPS
8.24
9.31
-11.49%
9.45
10.14
-6.80%
9.64
4.44
117.12%
7.69
7.34
4.77%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
3,791.13
3,517.98
2,488.34
Net Sales Growth
1.95%
-1.32%
0.39%
12.34%
20.05%
24.89%
-9.11%
7.76%
41.38%
 
Cost Of Goods Sold
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
1,471.11
1,352.42
986.26
Gross Profit
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
2,320.02
2,165.57
1,502.08
GP Margin
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
61.12%
61.20%
61.56%
60.36%
Total Expenditure
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
3,111.07
2,834.73
2,034.35
Power & Fuel Cost
333.66
366.71
393.04
389.74
356.73
286.89
224.04
220.03
197.91
170.43
% Of Sales
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
6.50%
5.80%
5.63%
6.85%
Employee Cost
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
718.54
735.21
648.49
375.71
% Of Sales
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
20.85%
19.39%
18.43%
15.10%
Manufacturing Exp.
428.84
436.46
432.40
405.14
360.48
329.75
284.66
315.90
293.91
230.80
% Of Sales
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
8.26%
8.33%
8.35%
9.28%
General & Admin Exp.
280.98
256.23
302.28
264.23
208.35
200.72
195.72
196.68
191.38
137.43
% Of Sales
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
5.68%
5.19%
5.44%
5.52%
Selling & Distn. Exp.
185.79
135.54
203.98
160.04
123.28
111.85
90.92
125.97
124.22
107.56
% Of Sales
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
2.64%
3.32%
3.53%
4.32%
Miscellaneous Exp.
53.20
65.96
39.72
19.59
23.53
28.50
27.21
46.18
26.41
107.56
% Of Sales
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
0.79%
1.22%
0.75%
1.05%
EBITDA
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
564.86
680.06
683.25
453.99
EBITDA Margin
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
16.39%
17.94%
19.42%
18.24%
Other Income
24.86
13.37
42.45
19.06
29.87
31.48
17.24
118.09
106.66
144.41
Interest
341.11
371.35
367.61
337.11
310.93
238.23
119.99
155.57
330.09
38.36
Depreciation
291.40
346.74
287.95
281.17
253.79
220.65
180.10
124.68
163.24
103.91
PBT
737.64
542.22
88.43
421.78
533.29
462.79
282.02
517.90
296.58
456.13
Tax
163.02
155.40
80.48
69.64
152.36
68.41
13.37
95.94
26.72
57.28
Tax Rate
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
5.56%
18.52%
9.01%
12.56%
PAT
575.66
391.83
-57.76
109.04
152.73
14.56
229.72
421.46
283.18
400.50
PAT before Minority Interest
574.63
386.82
-40.16
137.64
188.78
45.69
227.23
421.95
269.86
398.85
Minority Interest
1.03
5.01
-17.60
-28.60
-36.05
-31.13
2.49
-0.49
13.32
1.65
PAT Margin
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
6.67%
11.12%
8.05%
16.10%
PAT Growth
46.92%
778.38%
-152.97%
-28.61%
948.97%
-93.66%
-45.49%
48.83%
-29.29%
 
Unadjusted EPS
36.93
25.10
-3.63
6.85
9.59
0.91
14.42
28.56
19.22
27.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
2,201.34
1,542.64
1,256.20
Share Capital
15.57
15.54
15.93
15.45
15.93
15.93
15.93
15.88
14.76
14.62
Total Reserves
3,420.47
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
2,185.46
1,527.89
1,241.50
Non-Current Liabilities
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
3,365.15
4,056.86
2,238.68
Secured Loans
1,207.91
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
2,160.79
2,966.30
1,058.59
Unsecured Loans
2,297.13
392.79
375.00
0.22
760.06
0.45
400.61
1,011.94
975.49
1,049.87
Long Term Provisions
80.69
70.31
67.04
219.53
237.96
169.70
39.87
0.00
0.00
0.00
Current Liabilities
1,675.94
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
1,220.11
1,130.63
667.91
Trade Payables
749.49
612.12
721.19
718.14
647.13
836.98
517.43
688.83
584.06
306.65
Other Current Liabilities
572.70
951.43
793.31
1,731.20
898.00
499.55
465.94
64.70
88.72
65.14
Short Term Borrowings
255.60
748.97
517.17
1,187.83
1,131.39
767.07
883.03
0.00
0.00
0.00
Short Term Provisions
98.14
151.93
97.49
257.25
101.84
109.18
403.28
466.59
457.85
296.13
Total Liabilities
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.52
6,762.08
4,184.18
Net Block
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
3,818.89
3,745.00
1,912.42
Gross Block
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
4,845.26
4,648.26
2,495.91
Accumulated Depreciation
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
1,026.38
903.26
583.49
Non Current Assets
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
4,357.21
4,281.34
2,402.01
Capital Work in Progress
683.78
611.32
596.60
472.39
436.89
685.55
666.71
505.63
503.12
484.69
Non Current Investment
102.71
85.43
39.50
33.99
25.61
19.20
32.75
32.70
33.22
4.90
Long Term Loans & Adv.
56.32
62.67
327.17
328.42
379.47
299.86
249.18
0.00
0.00
0.00
Other Non Current Assets
1.08
0.53
29.68
2.21
0.37
0.79
0.55
0.00
0.00
0.00
Current Assets
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
2,455.22
2,205.31
1,780.52
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
223.71
238.13
40.73
Inventories
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
691.28
690.95
595.61
434.97
Sundry Debtors
1,005.30
950.50
819.27
805.87
708.54
652.69
520.45
518.61
504.41
425.78
Cash & Bank
459.63
344.58
394.34
479.53
356.05
266.82
1,045.14
503.67
381.66
523.77
Other Current Assets
262.79
377.13
265.59
301.21
380.29
357.59
334.88
518.27
485.49
355.27
Short Term Loans & Adv.
37.06
133.06
144.56
136.04
182.01
256.70
217.50
498.14
444.09
323.54
Net Current Assets
1,272.18
410.88
585.38
-966.38
-217.29
84.53
322.08
1,235.11
1,074.69
1,112.61
Total Assets
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.51
6,762.08
4,184.18

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
1,268.49
1,098.89
783.26
772.27
969.90
707.17
389.75
709.61
558.06
257.47
PBT
737.64
542.22
40.32
207.28
341.14
114.11
240.59
517.90
296.58
456.13
Adjustment
637.90
737.89
725.84
756.60
752.36
795.44
318.42
189.22
352.94
34.70
Changes in Working Capital
36.88
-133.16
96.40
-110.70
-4.04
-136.91
-84.14
62.58
-55.56
-185.10
Cash after chg. in Working capital
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
474.88
769.70
593.96
305.73
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
-60.57
-41.99
-45.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
-352.15
-279.75
-2,030.73
-1,139.35
Net Fixed Assets
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
-275.33
-128.63
-492.68
-281.91
Net Investments
-0.39
57.01
239.81
-27.56
-18.79
-95.66
5.14
-159.67
-331.27
-102.45
Others
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
-81.96
8.55
-1,206.78
-754.99
Cash from Financing Activity
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
608.21
-298.02
1,150.66
592.81
Net Cash Inflow / Outflow
132.22
-56.38
-62.76
183.44
20.41
-775.95
645.81
131.84
-322.01
-289.08
Opening Cash & Equivalents
339.27
391.64
473.49
279.65
263.08
1,041.15
498.27
381.66
523.77
874.91
Closing Cash & Equivalent
456.44
339.27
391.63
473.49
279.65
263.08
1,041.15
505.34
375.89
523.82

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
220.64
190.90
154.04
170.07
155.46
141.70
136.38
137.88
85.89
85.81
ROA
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
3.17%
6.21%
4.93%
10.75%
ROE
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
10.42%
24.42%
21.40%
36.99%
ROCE
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
6.29%
12.74%
14.62%
16.71%
Fixed Asset Turnover
1.09
0.92
0.81
0.84
0.82
0.78
0.70
0.82
1.02
1.26
Receivable days
59.43
54.81
49.56
46.53
47.00
48.71
53.83
48.18
46.63
50.03
Inventory Days
73.64
75.51
78.58
75.51
73.76
71.07
71.61
60.59
51.66
54.72
Payable days
54.84
53.44
52.17
51.42
45.33
38.70
50.95
58.42
49.77
49.78
Cash Conversion Cycle
78.23
76.88
75.98
70.61
75.42
81.08
74.50
50.34
48.52
54.97
Total Debt/Equity
1.18
1.51
1.95
1.67
1.71
1.69
1.81
1.45
3.11
1.68
Interest Cover
3.16
2.46
1.11
1.61
2.10
1.48
3.01
4.33
1.90
12.89

News Update


  • Jubilant Life Sciences issues commercial papers worth Rs 50 crore
    4th Nov 2017, 10:55 AM

    The aggregate amount of commercial papers outstanding as on date is Rs 100 crore

    Read More
  • Jubilant Life Sciences issues commercial papers worth Rs 50 crore
    18th Oct 2017, 11:13 AM

    The company has issued two commercial papers of Rs 25 crore each providing an interest rate of 6.50% p.a. and 6.48% p.a.

    Read More
  • Jubilant Life’s arm receives nod for RbES, proprietary RUBY consumable accessories
    3rd Oct 2017, 09:08 AM

    Jubilant Pharma has received approval from Health Canada

    Read More
  • Jubilant Life Sciences’ arm completes acquisition of Radiopharmacy business of Triad
    2nd Sep 2017, 09:48 AM

    The company intends to maintain and expand Triad’s distribution network

    Read More
  • Jubilant receives ANDA final approval for Indomethacin Capsules
    28th Aug 2017, 09:01 AM

    This is the seventh approval that the company has received from the USFDA during the current financial year

    Read More
  • Jubilant Life Sciences’ arm receives NDA approval for Drax Exametazime
    21st Aug 2017, 14:51 PM

    This is the sixth approval that the company has received from the USFDA during the current financial year

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.